Michael Gelband’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6M Buy
+76,693
New +$5.23M 0.04% 436
2025
Q3
Sell
-86,055
Closed -$4.48M 1732
2025
Q2
$4.48M Buy
+86,055
New +$4.9M 0.04% 458
2023
Q4
Sell
-52,558
Closed -$2.01M 1701
2023
Q3
$2.01M Sell
52,558
-287,405
-85% -$11.8M 0.02% 675
2023
Q2
$12.3M Buy
339,963
+186,111
+121% +$6.35M 0.1% 207
2023
Q1
$5.88M Buy
153,852
+56,604
+58% +$2.66M 0.05% 461
2022
Q4
$5.53M Sell
97,248
-1,735
-2% -$88.8K 0.08% 324
2022
Q3
$3.91M Sell
98,983
-61,296
-38% -$2.71M 0.05% 495
2022
Q2
$7.05M Buy
160,279
+32,411
+25% +$1.4M 0.09% 291
2022
Q1
$5.1M Buy
127,868
+72,636
+132% +$2.59M 0.06% 382
2021
Q4
$2.22M Buy
+55,232
New +$2.06M 0.02% 716
2021
Q2
Sell
-32,161
Closed -$1.34M 2530
2021
Q1
$1.34M Buy
+32,161
New +$1.47M 0.02% 755
2020
Q4
Sell
-51,617
Closed -$1.36M 2116
2020
Q3
$1.36M Buy
51,617
+3,054
+6% +$85K 0.03% 552
2020
Q2
$1.3M Buy
+48,563
New +$1.1M 0.03% 609
2020
Q1
Sell
-27,032
Closed -$479K 1301
2019
Q4
$479K Buy
+27,032
New +$468K 0.01% 886

Other funds holding HALO

Michael Gelband's HALO Position: Q2 2026 in Review

Michael Gelband opened a new position in Halozyme (HALO) in Q2 2026: 76,693 shares worth $6M. The stake represents 0.04% of the portfolio and ranks #436 among its holdings. This is a return to the name: Michael Gelband previously reported a position in HALO as recently as Q2 2025.

Michael Gelband first reported a position in HALO in Q4 2019 and has held it in 14 quarters since. The position peaked at $12.3M in Q2 2023. 665 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Michael Gelband held 76,693 shares of Halozyme worth $6M as of Q2 2026.
  • Halozyme was a new Michael Gelband position in Q2 2026.
  • Halozyme made up 0.04% of Michael Gelband's portfolio in Q2 2026, its #436 holding.
  • Michael Gelband first reported a position in Halozyme in Q4 2019 and has held it in 14 quarters since.
  • Michael Gelband's Halozyme position peaked at $12.3M in Q2 2023.
  • 665 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.